In the spirit of modern ‘lifetime management’, consideration should therefore be given as early as the first procedure to which options remain open for subsequent interventions – such as transcatheter aortic valve implantation (TAVI) within...
In the spirit of modern ‘lifetime management’, consideration should therefore be given as early as the first procedure to which options remain open for subsequent interventions – such as transcatheter aortic valve implantation (TAVI) within...
WASHINGTON — Exercise should be prescribed as a foundational component of cardiovascular disease (CVD) prevention and treatment, according to a new American College of Cardiology Scientific Statement published today...
WASHINGTON — Exercise should be prescribed as a foundational component of cardiovascular disease (CVD) prevention and treatment, according to a new American College of Cardiology Scientific Statement published today...
The Paradise™ Ultrasound Renal Denervation (uRDN) system has been recognized by TIME with a Best Inventions of 2026 award in the Medical and Healthcare category.
The Paradise™ Ultrasound Renal Denervation (uRDN) system has been recognized by TIME with a Best Inventions of 2026 award in the Medical and Healthcare category.
MyFit™ by Biogel® is designed to better reflect the diversity of clinicians’ hand anatomy and help more healthcare professionals find a glove that supports comfort, safety and performance – all critical in the operating room.
MyFit™ by Biogel® is designed to better reflect the diversity of clinicians’ hand anatomy and help more healthcare professionals find a glove that supports comfort, safety and performance – all critical in the operating room.
SAN DIEGO -- REVA Medical, LLC announced the successful completion of a live case demonstration featuring the MOTIV® sirolimus-eluting bioresorbable vascular scaffold and the presentation of late-breaking clinical results from the...
SAN DIEGO -- REVA Medical, LLC announced the successful completion of a live case demonstration featuring the MOTIV® sirolimus-eluting bioresorbable vascular scaffold and the presentation of late-breaking clinical results from the...
Operated with Clear Heart and Lung, the unit enables patients in communities without cardiac CT to join Cleerly's TRANSFORM, a trial testing whether treatment guided by coronary artery disease staging prevents heart attacks.
Operated with Clear Heart and Lung, the unit enables patients in communities without cardiac CT to join Cleerly's TRANSFORM, a trial testing whether treatment guided by coronary artery disease staging prevents heart attacks.
Final late-breaking VIVA26 studies reported new data on the Revello™ covered stent for iliac artery disease, Neuroguard IEP carotid stenting outcomes, and early real-world use of the Rotarex™ atherectomy system in CLTI.
Final late-breaking VIVA26 studies reported new data on the Revello™ covered stent for iliac artery disease, Neuroguard IEP carotid stenting outcomes, and early real-world use of the Rotarex™ atherectomy system in CLTI.
Late-breaking VIVA26 studies reported on IVL for calcified PAD, transdermal oxygen therapy after LE revascularization, transcatheter arterialization for no-option CLTI, and DES outcomes in complex femoropopliteal disease.
Late-breaking VIVA26 studies reported on IVL for calcified PAD, transdermal oxygen therapy after LE revascularization, transcatheter arterialization for no-option CLTI, and DES outcomes in complex femoropopliteal disease.
